The higher the percentage of GOLPH3 positive cancer cells (“A” score in IRS scale) in the prostate and the higher the staining intensity (“B” score in IRS scale) in the metastatic lymph node, the efficacy of RP was lower (p<0.05). Here, GOLPH3 is linked to cancer.